[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74419]], camposKey:1661-7827 2023-03-01 COVID-19 Pandemic Control Measures and Their Impact on University Students and Family Members in a Central Region of Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80382]], camposKey:1929-0748 2023-01-01 Short-Wavelength Light¿Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75140]], camposKey:1542-0124 2022-10-01 Phenotypic characterization of patients developing chronic dry eye and pain after refractive surgery: A cross-sectional study6374, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72043]], camposKey:0014-4835 2022-06-01 Hair cortisol level as a molecular biomarker in retinitis pigmentosa patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72871]], camposKey:0014-4835 2022-06-01 Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76049]], camposKey:0275-004X 2022-03-01 CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature465475, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52925]], camposKey:1177-5467 2020-01-01 Evaluation of Potential Pain Biomarkers in Saliva and Pain Perception After Corneal Advanced Surface Ablation Surgery613623, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49608]], camposKey:1177-5467 2017-01-01 Pain perception description after advanced surface ablation647655, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46977]], camposKey:1932-6203 2016-01-01 Reliability of Potential Pain Biomarkers in the Saliva of Healthy Subjects: Inter-Individual Differences and Intersession Variability00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49612]], camposKey:1177-5467 2015-01-01 Ocular pain and discomfort after advanced surface ablation: An ignored complaint16251632][][][][][][][][][][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@9716aa9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6ce75731][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6524b7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6524aa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6524b8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651d8e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65230b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652433, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@652319, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d8828, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a51, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651afd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a74, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373391, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@650f66][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3836], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c2ff3], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bf57b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@465521], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@463421], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c4009], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4131c3]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17559, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17876, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16ef0, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16bd9, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15df1, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@161a7, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13c5a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@13c52][]